Statistical Analysis
hemorrhagic, bleeding
REGRESSION, EVENTS, EVENT, BLEEDING
Baseline characteristics are presented by antiplatelet treatment groups (ticagrelor-aspirin or clopidogrel-aspirin) and Participants were censored at their last follow-up assessment when experiencing a clinical event, at the end of the study, or at the time of withdrawal from the study. When there were multiple events of the same type, the time to the first event was used in the model. The cumulative risks of any ischemic or hemorrhagic event and of bleeding events during the 90-day follow-up were reported as Kaplan-Meier estimates. Cox proportional hazards regression methods were used for calculation of hazard ratios (HRs) and 95% CIs. Differences in time to the first event between study groups within the 